Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.27.4 (
ribonuclease
)
6,621
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Bone morphogenetic proteins (BMPs) occupy important roles during development serving to direct cells through specific differentiation programs. While several BMPs are essential for embryonic viability, their significance in mediating intercellular communication in the context of adult organ systems remains largely unknown. In the adult rat we characterized the tissue- and cell-specific transcription and translation of
BMP-9
. Utilizing a
ribonuclease
protection assay, we determined that in the adult animal,
BMP-9
expression occurs predominantly in the liver. Furthermore, we determined that the non-parenchymal cells of the liver, i.e. endothelial, Kupffer, and stellate cells, are the major sources of this message. Western analyses corroborate the
ribonuclease
protection assay results, confirming that LEC and KC contain an abundance of immunoreactive
BMP-9
. Using [(125)I]
BMP-9
, a receptor with specific binding affinity for
BMP-9
was characterized in primary cultures of hepatic endothelial cells and Kupffer cells.
BMP-9
binding to these cell types was observed to be fully reversible and highly specific for this ligand. Additionally, we demonstrate that
BMP-9
is specifically internalized upon binding to its receptor. This may represent a novel BMP receptor and is the first to be characterized in primary cultures of mature liver non-parenchymal cells. Our results depict
BMP-9
as a potential autocrine/paracrine mediator in the hepatic reticuloendothelial system.
...
PMID:Bone morphogenetic protein-9. An autocrine/paracrine cytokine in the liver. 1084 32